MicroSintesis Inc.
$238,293.00 CAD
≈ 3 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- May 1, 2023 – March 31, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q2-1007347
Published purpose
MicroSintesis is developing a Bioassay Platform that will be used to determine the potency of current and future products, and to validate the anti-virulence mode of action of candidate products against target pathogens of commercial interest. The collection of analytical and biological assays for the Bioassay Platform will monitor: 1) Virulence and Quorum Sensing Gene Expression changes, in selected pathogens, to the presence of the technology 2) Phenotypic behavioural response of selected pathogen to virulence gene changes 3) In vivo Clinical response to pathogen behaviour changes due to quorum inhibition
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions